The importance of early diagnosis and treatment of kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon
Kaposiform hemangioendothelioma (KHE) is a locally aggressive vascular tumor that may be complicated by Kasabach-Merritt phenomenon (KMP), a profound thrombocytopenia resulting from platelet trapping within a vascular tumor, either KHE or tufted angioma (TA). Typical features also include low fibri...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Mattioli1885
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e91ec3558c7a47f5bd89f34fd50fc022 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e91ec3558c7a47f5bd89f34fd50fc022 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e91ec3558c7a47f5bd89f34fd50fc0222021-11-17T08:31:48ZThe importance of early diagnosis and treatment of kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon10.5826/dpc.0501a182160-9381https://doaj.org/article/e91ec3558c7a47f5bd89f34fd50fc0222015-01-01T00:00:00Zhttp://dpcj.org/index.php/dpc/article/view/865https://doaj.org/toc/2160-9381 Kaposiform hemangioendothelioma (KHE) is a locally aggressive vascular tumor that may be complicated by Kasabach-Merritt phenomenon (KMP), a profound thrombocytopenia resulting from platelet trapping within a vascular tumor, either KHE or tufted angioma (TA). Typical features also include low fibrinogen and elevated D-dimers. It is well known that KMP is not caused by infantile hemangiomas. Management of vascular tumors complicated by KMP is challenging, and it is common for referral centers to receive patients in critical medical condition after multimodality treatment failure of vascular anomalies. Our aim is to communicate the importance of early diagnosis and treatment of KHE associated with KMP. A full-term male newborn with KHE complicated by KMP is reported. Treatment with vincristine, aspirin and ticlopidine normalized the coagulation parameters within one week, requiring a total of six doses of vincristine, seven months of ticlopidine and 17 months of aspirin. Early diagnosis and treatment of KHE complicated by KMP may allow the administration of fewer doses of vincristine and avoid the use of corticosteroids. Grecia V. Vivas-ColmenaresGema L. Ramirez-VillarJose A. Matute de CardenasJose Bernabeu-WittelIsrael Fernandez-PinedaMattioli1885articlekaposiform hemangioendotheliomaKasabach-Merritt phenomenonvincristineticlopidineaspirinDermatologyRL1-803ENDermatology Practical & Conceptual (2015) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
kaposiform hemangioendothelioma Kasabach-Merritt phenomenon vincristine ticlopidine aspirin Dermatology RL1-803 |
spellingShingle |
kaposiform hemangioendothelioma Kasabach-Merritt phenomenon vincristine ticlopidine aspirin Dermatology RL1-803 Grecia V. Vivas-Colmenares Gema L. Ramirez-Villar Jose A. Matute de Cardenas Jose Bernabeu-Wittel Israel Fernandez-Pineda The importance of early diagnosis and treatment of kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon |
description |
Kaposiform hemangioendothelioma (KHE) is a locally aggressive vascular tumor that may be complicated by Kasabach-Merritt phenomenon (KMP), a profound thrombocytopenia resulting from platelet trapping within a vascular tumor, either KHE or tufted angioma (TA). Typical features also include low fibrinogen and elevated D-dimers. It is well known that KMP is not caused by infantile hemangiomas. Management of vascular tumors complicated by KMP is challenging, and it is common for referral centers to receive patients in critical medical condition after multimodality treatment failure of vascular anomalies. Our aim is to communicate the importance of early diagnosis and treatment of KHE associated with KMP. A full-term male newborn with KHE complicated by KMP is reported. Treatment with vincristine, aspirin and ticlopidine normalized the coagulation parameters within one week, requiring a total of six doses of vincristine, seven months of ticlopidine and 17 months of aspirin. Early diagnosis and treatment of KHE complicated by KMP may allow the administration of fewer doses of vincristine and avoid the use of corticosteroids.
|
format |
article |
author |
Grecia V. Vivas-Colmenares Gema L. Ramirez-Villar Jose A. Matute de Cardenas Jose Bernabeu-Wittel Israel Fernandez-Pineda |
author_facet |
Grecia V. Vivas-Colmenares Gema L. Ramirez-Villar Jose A. Matute de Cardenas Jose Bernabeu-Wittel Israel Fernandez-Pineda |
author_sort |
Grecia V. Vivas-Colmenares |
title |
The importance of early diagnosis and treatment of kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon |
title_short |
The importance of early diagnosis and treatment of kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon |
title_full |
The importance of early diagnosis and treatment of kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon |
title_fullStr |
The importance of early diagnosis and treatment of kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon |
title_full_unstemmed |
The importance of early diagnosis and treatment of kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon |
title_sort |
importance of early diagnosis and treatment of kaposiform hemangioendothelioma complicated by kasabach-merritt phenomenon |
publisher |
Mattioli1885 |
publishDate |
2015 |
url |
https://doaj.org/article/e91ec3558c7a47f5bd89f34fd50fc022 |
work_keys_str_mv |
AT greciavvivascolmenares theimportanceofearlydiagnosisandtreatmentofkaposiformhemangioendotheliomacomplicatedbykasabachmerrittphenomenon AT gemalramirezvillar theimportanceofearlydiagnosisandtreatmentofkaposiformhemangioendotheliomacomplicatedbykasabachmerrittphenomenon AT joseamatutedecardenas theimportanceofearlydiagnosisandtreatmentofkaposiformhemangioendotheliomacomplicatedbykasabachmerrittphenomenon AT josebernabeuwittel theimportanceofearlydiagnosisandtreatmentofkaposiformhemangioendotheliomacomplicatedbykasabachmerrittphenomenon AT israelfernandezpineda theimportanceofearlydiagnosisandtreatmentofkaposiformhemangioendotheliomacomplicatedbykasabachmerrittphenomenon AT greciavvivascolmenares importanceofearlydiagnosisandtreatmentofkaposiformhemangioendotheliomacomplicatedbykasabachmerrittphenomenon AT gemalramirezvillar importanceofearlydiagnosisandtreatmentofkaposiformhemangioendotheliomacomplicatedbykasabachmerrittphenomenon AT joseamatutedecardenas importanceofearlydiagnosisandtreatmentofkaposiformhemangioendotheliomacomplicatedbykasabachmerrittphenomenon AT josebernabeuwittel importanceofearlydiagnosisandtreatmentofkaposiformhemangioendotheliomacomplicatedbykasabachmerrittphenomenon AT israelfernandezpineda importanceofearlydiagnosisandtreatmentofkaposiformhemangioendotheliomacomplicatedbykasabachmerrittphenomenon |
_version_ |
1718425706844651520 |